GLD News 123.19 08/25/2014 05:10:07 SPDR Gold (GLD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPDR Gold (GLD) 123.19 $GLD

Jim Cramer's 'Mad Money' Recap: Cramer Opens His Playbook
at The Street - Fri Aug 22, 6:00PM CDT
One thing America's education system does not teach is financial literacy, says 'Professor' Cramer.

Critical Alerts For Advanced Micro Devices, SPDR Gold Trust, Express Scripts, Qualcomm and Urban Outfitters Released By InvestorsObserver
PR Newswire - Fri Aug 22, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AMD, GLD, ESRX, QCOM and URBN.

Watch for SPDR Gold Trust to Potentially Rebound After Falling 1.08% Yesterday
Comtex SmarTrend(R) - Thu Aug 21, 3:41PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $122.45 to a high of $123.24. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $123.88 on volume of 8.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of SPDR Gold Trust to Potentially Rebound after Yesterday's 1.08% Sell Off
Comtex SmarTrend(R) - Thu Aug 21, 3:40PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $122.45 to a high of $123.24. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $123.88 on volume of 8.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Economic Recovery Doesn't Satisfy Fed as Stocks Soar Higher
at The Street - Thu Aug 21, 10:14AM CDT
Low inflation and slack in the labor market has kept policymakers dovish, leading to strength in U.S. equities and in high-beta sectors.

Corn Futures in Focus: Can the Slump Continue? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Aug 18, 5:32PM CDT
What is the near term outlook for corn prices?

The Zacks Analyst Blog Highlights:iShares 20+ Year Treasury Bond ETF, 25+ Year Zero Coupon U.S. Treasury Index Fund,SPDR Gold Trust ETF, COMEX Gold Trust and CurrencyShares Japanese Yen Trust
PR Newswire - Thu Aug 14, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iShares 20+ Year Treasury Bond ETF (AMEX:TLT-Free Report), 25+ Year Zero Coupon U.S. Treasury Index Fund (AMEX:ZROZ-Free Report), SPDR Gold Trust ETF (AMEX:GLD-Free Report), COMEX Gold Trust (AMEX:IAU-Free Report) and CurrencyShares Japanese Yen Trust (AMEX:FXY-Free Report).

Gold Demand Shrinks a Year After the Infamous Market Collapse
at The Street - Wed Aug 13, 11:01PM CDT
Gold demand drops about 16% in the second quarter of 2014, the World Gold Council says.

Gold Miners' Stocks Are Hit by Strife, but Hold Long Term Value
at The Street - Wed Aug 13, 1:15PM CDT
Gold mining shares are missing growth expectations as geopolitical strife heightens, but watch as the sector still holds long term value.

3 Safe Haven ETFs to Beat a Summer Slowdown - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 9:00AM CDT
These safe haven ETFs should hold up better than most in the current economic environment.

Is Time Ripe for Gold Mining ETFs Amid Rising Tensions? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Aug 07, 12:00PM CDT
Given mixed sentiments, investors should carefully watch for developments in the gold mining ETF space in the coming months.

Is Corporate Debt Reaching Dangerous Levels? - Real Time Insight
Neena Mishra - Zacks Investment Research - Thu Aug 07, 9:34AM CDT
High levels of corporate debt may pose a risk when interest rates start rising.

Will Gold���s Recent Rally Last -- or Will It Evaporate?
at The Street - Thu Aug 07, 5:00AM CDT
Will gold���s recent recovery continue in the near term?

SmarTrend Watching for Potential Pullback in Shares of SPDR Gold Trust After 1.45% Gain
Comtex SmarTrend(R) - Wed Aug 06, 3:42PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $125.52 to a high of $126.00. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $124.81 on volume of 9.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SPDR Gold Trust Rises 1.45% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Aug 06, 3:41PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $125.52 to a high of $126.00. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $124.81 on volume of 9.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Will Silver Wheaton Deal With Vale for Salobo Gold Mine Pay Off?
at The Street - Wed Aug 06, 5:00AM CDT
Will Silver Wheaton���s Salobo mine, which was added to its portfolio last year, pay off now that the price of gold has dropped down the shaft?

S&P 500 Continues to Fly Its Bear Flag
at The Street - Tue Aug 05, 3:38PM CDT
Why put money at risk when it is too dangerous to do so?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Hit with Lawsuit Over Misleading Claims

Updated Category News Views 6

Unpacking Beta Bionics' Legal Storm Investors in Beta Bionics, Inc. —ticker BBNX—are probably feeling like they're caught in a whirlwind right now, and who can blame them? The company's facing a class action lawsuit, and the accusations aren't anything to sniff at. They're talking about violations of the Securities Exchange Act of 1934, along with some shady...

Continue Reading
Mountain Living: Facing the Population Growth Crunch

Updated Category News Views 0

Population Growth Reshaping U.S. Mountain Communities Living in a picturesque mountain town used to offer an idyllic escape from the hustle and bustle of city life. But now, even these scenic enclaves are feeling the squeeze from a wave of population growth that's hard to ignore. Mark Cromer tackles this head-on in his new Forum paper, 'The Long Goodnight of Rocky...

Continue Reading
Kenneth Spells: Championing Education Leadership in 2026

Updated Category News Views 3

Out there in Hoke County, you’ve got a man named Kenneth Spells shaking things up the way a strong leader should. Now, you know I’m not here to fluff up anyone’s feathers—especially in an arena as aching for reform as education. But credit where credit’s due, Spells picked up the ‘2026 Professional of the Year’ from The Inner Circle for a reason, and it’s...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 4

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading
DICK'S Sporting Goods Faces Legal Challenges in Securities Suit

Updated Category News Views 4

Trouble Brewing at DICK'S Sporting Goods Wall Street's not only about the wins. There are moments when the market throws a curveball, and right now, DICK'S Sporting Goods is facing a fast one. DJS Law Group just laid out a class action lawsuit accusing them of bending the securities law rules. It ain't pretty when a company gets tangled up in legal battles, but it's...

Continue Reading
Meitav Tops 2025 Service Index with Stellar Growth

Updated Category News Views 6

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Continue Reading
CAR T-Cell Therapy Offers New Hope for SPS Patients

Updated Category News Views 0

Game-changing Developments in CAR T-Cell Therapy Leaping straight into the meat of it—our friends at the University of Colorado Anschutz are onto something big. They've wrapped up a study pushing the boundaries of CAR T-cell therapy, and let me tell you, it looks like a real game-changer for those battling the rare beast known as stiff person syndrome (SPS). Breaking...

Continue Reading
Software Tax Hits Enterprises: Costly Control Concerns

Updated Category News Views 16

Unanticipated Software Costs: Who's in Charge? Picture this: you're running a tech setup at a major corporation, but the software changes thrust upon you aren't anything you would've chosen freely. Yeah, that's about one in four dollars from your hot little budget spent on tweaks and adjustments you didn’t ask for. And it's not as glamorous as it sounds—more like a...

Continue Reading
Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Updated Category News Views 8

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

Continue Reading
Tax Strategy Crucial: Sidnell & Webster of Lufkin Weigh In

Updated Category News Views 4

Breaking Down Tax Prep vs. Planning Ever wonder why some folks never break a sweat come tax season, while others scramble like their hair's on fire? It all boils down to understanding two very different animals: tax preparation and tax planning. CPA veterans Yvette Sidnell and Jennifer Webster over in Lufkin, Texas, have laid it out crystal clear in their article with...

Continue Reading

Top 5 Most Recently Viewed Articles

Rancho Mission Viejo: Leading the Way in Wellness Real Estate

Updated Category News Views 202

Rancho Mission Viejo Recognized Globally for Wellness Development The Ranch stands out as a model for wellness communities and showcases the impact on individual lives. This 23,000-acre master-planned community and functional cattle ranch has achieved global recognition as one of the largest intentional wellness real estate developments. A Testament to Community Design As...

Continue Reading
Revolutionizing Patient Access with AI: The New Trial Finder

Updated Category News Views 177

Introducing the Future of Clinical Trials The world of radiopharmaceuticals is changing rapidly, with an innovative new tool set to revolutionize the way patients and healthcare providers access critical information about clinical trials. The Radiopharmaceutical Trial Finder, backed by the ICPO Foundation, was developed through a collaboration between WARMTH and...

Continue Reading
Semler Scientific Faces Legal Challenges Amid Controversy

Updated Category News Views 157

Semler Scientific Under Legal Scrutiny Semler Scientific, Inc. is currently facing a class action lawsuit that sheds light on serious allegations regarding their securities practices. Shareholders of the company, identified by the ticker SMLR, are encouraged to be proactive amidst these developments. The lawsuit primarily alleges violations of federal securities exchanges...

Continue Reading
Charles Dayoub Joins The Willis Law Group Fraud Team

Updated Category News Views 207

Charles Dayoub Enhances The Willis Law Group’s Fraud Team We are delighted to announce that Charles Dayoub has joined The Willis Law Group P.L.L.C., bringing with him a wealth of experience with over 18 years in law and extensive expertise in executive positions. His previous role at a prominent law firm involved dealing with government receivables and regulatory...

Continue Reading
Evaluating Revolution Medicines' Future Potential and Progress

Updated Category News Views 168

Revolution Medicines Maintains Positive Outlook Piper Sandler has sustained an optimistic outlook regarding Revolution Medicines (NASDAQ: RVMD), reaffirming its Overweight rating with a specified price target of $57.00. This commitment to the stock's rating comes after recent developments linked to the company’s Phase I trial, which is focused on RMC-6236, a potential...

Continue Reading